Literature DB >> 18974487

Progression of chronic pulmonary tuberculosis in mice intravenously infected with ethambutol resistant Mycobacterium tuberculosis.

S Srivastava1, A Ayyagari, T N Dhole, N Krishnani, K K Nyati, S K Dwivedi.   

Abstract

PURPOSE: Ethambutol (EMB) is an important first line drug, however little information on its molecular mechanism of resistance and pathogenicity of resistant isolates is available. Present work was designed to study virulence of the EMB resistant M. tuberculosis strains and the host responses in-vivo on infection of EMB resistant M. tuberculosis using Balb/c mouse model of infection.
METHODS: Three groups of Balb/c mice (female, age 4-6 wk; 21 mice in each group) were infected intravenously with 106 CFU of M. tuberculosis H37Rv and two EMB resistant clinical isolates. Age and sex matched control animals were mock inoculated with Middlebrook 7H9 broth alone. At 10, 20, 30, 40, 50, 60, and 70 days post-infection three animals from each group were sacrificed by cervical dislocation and lung tissue was collected for further analysis.
RESULTS: Infection with EMB resistant M. tuberculosis led to progressive and chronic disease with significantly high bacillary load (p=0.02). Massive infiltration and exacerbated lung pathology with increased expression of IFN-gamma and TNF-alpha was observed in lungs of mice infected with EMB resistant strains. The present study suggests that infection with EMB resistant M. tuberculosis leads to chronic infection with subsequent loss of lung function, bacterial persistence with elevated expression of TNF-alpha resulting in increased lung pathology.
CONCLUSION: These findings highlight that EMB resistant M. tuberculosis regulates host immune response differentially and its pathogenicity is different from drug sensitive strains of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974487     DOI: 10.4103/0255-0857.42124

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  4 in total

1.  How "humane" is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection.

Authors:  Nuno H Franco; Margarida Correia-Neves; I Anna S Olsson
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

2.  Investigation of Immune Biomarkers Using Subcutaneous Model of M. tuberculosis Infection in BALB/c Mice: A Preliminary Report.

Authors:  Aliabbas A Husain; Hatim F Daginawala; Shubangi R Warke; Devanand R Kalorey; Nitin V Kurkure; Hemant J Purohit; Girdhar M Taori; Rajpal S Kashyap
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

3.  Effects of hMASP-2 on the formation of BCG infection-induced granuloma in the lungs of BALB/c mice.

Authors:  Xiaoying Xu; Xiaoling Lu; Xingfang Dong; Yanping Luo; Qian Wang; Xun Liu; Jie Fu; Yuan Zhang; Bingdong Zhu; Xingming Ma
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

4.  Oxidative responses and defense mechanism of hyperpigmented P. aeruginosa as characterized by proteomics and metabolomics.

Authors:  Chadinee Thippakorn; Chartchalerm Isarankura-Na-Ayudhya; Supitcha Pannengpetch; Patcharee Isarankura-Na-Ayudhya; Nalini Schaduangrat; Chanin Nantasenamat; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2018-06-13       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.